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The huge dosage of radioactive Au198 is given intraperitoneally for mice, D. D. S. 
strain, 40 days old at the hyperbaric enviroment. The injection of glutathione (Tachione) 
before the exposure of the increased ambient pressure, seems to induce the mortalitie~of 
mice due to the inhibitiions of oxygenation mechanism in cels by both or either radioac-
tive function and the hyperbaric oxygenation, ten days after the procedures of the a出帆
Also if the synthetic glutathione (Tachione) is injected with any plasma expanders, for 
instance, Low Molecular Dextrane to the hemorrhagic shock dogs after bleeding at dog, 
treated by the hyperbaric oxygenation therapy, the possibilities in succeeding the hyperbaric 




























































































































































Numbers nf Surival mICe (40 ［）；《り、 Old,D.D.S.）合
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Protective Effects nf Gluth~ tione Against Radioac・liveLesion Aum (250 Mc/ kg) 
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結果 I--, I 
［加圧iポタム｜減圧
脱血後15’死亡 0 ! 0 0 
脱血後40’死亡 1 o I o o 
脱血後75’死亡｜ O I o o 
26 : 1 ｜脱血後185’死亡 11'' 1°30’ 35’ 
n I 1 1脱血後初’死亡 1 12’1 1 °30' 35' 








12’ 1°30’ 35’ 
11' I 1°24’I 35’ 
15’！ 1°15' 35’ 
Dextrane Normal Dextrane Hyperbaric Dextrane + Gluthatione 
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←」：：： m Time 
←ー」こ~ress1on
8. 2kg 5. Okg 5. 2kg 7. 5kg 8. 8kg 7. Okg 7. Okg 8. Okg 8. Okg 
400ml 450ml 7 401nl 600mf 600,,J 5001nl 400mi 5001nl 600ml 
図 B 日urv1v;ilTime after Hemorrhage at Hyperbaric Research 
(up : weighing each no日J (down : Volume of arterial Blood drawn l 
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